Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer
Purpose: Cure- and toxicity rates of prostate IGRT can both be affected by ill-chosen planning target volume (PTV) margins. For dose-escalated prostate radiotherapy, we studied the potential for organ at risk (OAR) sparing and compensation of prostate motion with robust plan optimization using the c...
Saved in:
Published in | Acta oncologica Vol. 59; no. 8; pp. 911 - 917 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Taylor & Francis
02.08.2020
|
Online Access | Get full text |
ISSN | 0284-186X 1651-226X 1651-226X |
DOI | 10.1080/0284186X.2020.1760349 |
Cover
Abstract | Purpose: Cure- and toxicity rates of prostate IGRT can both be affected by ill-chosen planning target volume (PTV) margins. For dose-escalated prostate radiotherapy, we studied the potential for organ at risk (OAR) sparing and compensation of prostate motion with robust plan optimization using the coverage probability (CovP) concept compared to conventional PTV-based IMRT.
Material and methods: We evaluated plan quality of CovP-plans for 27 intermediate risk prostate cancer patients treated in a prospective study (78 Gy/39 fractions). Clinical target volume (CTV) and OARs were contoured on three separate CTs to capture movement and deformation. To define the internal target volume (ITV), the union of CTV1-3 was encompassed by an isotropic margin of 7 mm for the planning process. CovP-dose distribution is optimized considering weight factors for IMRT constraints derived from probabilities of systematic organ displacement in the three CTs. CovP-dose volume histograms (DVHs) were compared with additionally calculated conventional PTV-based IMRT plans. PTV-based IMRT was planned on one-single CT with an isotropically expanded CTV to generate the PTV (i.e., CTV1 + 7mm) and was evaluated on the two other CTs.
Results: The CovP-concept showed higher robustness in target volume coverage. Target miss was frequently observed with PTV-based IMRT, resulting in cold spots until 70 Gy with the CovP-concept. The target dose at 74 Gy was comparable, while further the dose-escalation (75-78 Gy) was improved with PTV-based IMRT. However, dose-escalation with PTV-based IMRT was associated with increased OAR-doses, especially in high-dose areas.
Conclusions: Probabilistic dose-escalated IMRT was feasible in this prospective study. Comparison of the CovP-concept with PTV-based IMRT revealed superiority with regard to target-coverage and sparing of OARs. The CovP-concept implements a robust plan optimization strategy for organ deformation and motions and could, therefore, serve as a less demanding compromise on the way to adaptive IGRT avoiding daily time-consuming re-planning.
SUMMARY
We evaluated the robustness of coverage probability (CovP)-based IMRT plans within a prospective study for prostate cancer radiotherapy. The treatment plans were compared with newly calculated conventional PTV-based IMRT plans. We were able to show that CovP led to a clearly more robust target coverage by avoiding hot spots at OARs compared to conventional PTV-based IMRT. In addition, negative consequences of an inflated PTV can be ameliorated by a more relaxed CovP-based dose prescription. |
---|---|
AbstractList | Cure- and toxicity rates of prostate IGRT can both be affected by ill-chosen planning target volume (PTV) margins. For dose-escalated prostate radiotherapy, we studied the potential for organ at risk (OAR) sparing and compensation of prostate motion with robust plan optimization using the coverage probability (CovP) concept compared to conventional PTV-based IMRT.
We evaluated plan quality of CovP-plans for 27 intermediate risk prostate cancer patients treated in a prospective study (78 Gy/39 fractions). Clinical target volume (CTV) and OARs were contoured on three separate CTs to capture movement and deformation. To define the internal target volume (ITV), the union of CTV1-3 was encompassed by an isotropic margin of 7 mm for the planning process. CovP-dose distribution is optimized considering weight factors for IMRT constraints derived from probabilities of systematic organ displacement in the three CTs. CovP-dose volume histograms (DVHs) were compared with additionally calculated conventional PTV-based IMRT plans. PTV-based IMRT was planned on one-single CT with an isotropically expanded CTV to generate the PTV (i.e., CTV1 + 7mm) and was evaluated on the two other CTs.
The CovP-concept showed higher robustness in target volume coverage. Target miss was frequently observed with PTV-based IMRT, resulting in cold spots until 70 Gy with the CovP-concept. The target dose at 74 Gy was comparable, while further the dose-escalation (75-78 Gy) was improved with PTV-based IMRT. However, dose-escalation with PTV-based IMRT was associated with increased OAR-doses, especially in high-dose areas.
Probabilistic dose-escalated IMRT was feasible in this prospective study. Comparison of the CovP-concept with PTV-based IMRT revealed superiority with regard to target-coverage and sparing of OARs. The CovP-concept implements a robust plan optimization strategy for organ deformation and motions and could, therefore, serve as a less demanding compromise on the way to adaptive IGRT avoiding daily time-consuming re-planning. SUMMARYWe evaluated the robustness of coverage probability (CovP)-based IMRT plans within a prospective study for prostate cancer radiotherapy. The treatment plans were compared with newly calculated conventional PTV-based IMRT plans. We were able to show that CovP led to a clearly more robust target coverage by avoiding hot spots at OARs compared to conventional PTV-based IMRT. In addition, negative consequences of an inflated PTV can be ameliorated by a more relaxed CovP-based dose prescription. Purpose: Cure- and toxicity rates of prostate IGRT can both be affected by ill-chosen planning target volume (PTV) margins. For dose-escalated prostate radiotherapy, we studied the potential for organ at risk (OAR) sparing and compensation of prostate motion with robust plan optimization using the coverage probability (CovP) concept compared to conventional PTV-based IMRT. Material and methods: We evaluated plan quality of CovP-plans for 27 intermediate risk prostate cancer patients treated in a prospective study (78 Gy/39 fractions). Clinical target volume (CTV) and OARs were contoured on three separate CTs to capture movement and deformation. To define the internal target volume (ITV), the union of CTV1-3 was encompassed by an isotropic margin of 7 mm for the planning process. CovP-dose distribution is optimized considering weight factors for IMRT constraints derived from probabilities of systematic organ displacement in the three CTs. CovP-dose volume histograms (DVHs) were compared with additionally calculated conventional PTV-based IMRT plans. PTV-based IMRT was planned on one-single CT with an isotropically expanded CTV to generate the PTV (i.e., CTV1 + 7mm) and was evaluated on the two other CTs. Results: The CovP-concept showed higher robustness in target volume coverage. Target miss was frequently observed with PTV-based IMRT, resulting in cold spots until 70 Gy with the CovP-concept. The target dose at 74 Gy was comparable, while further the dose-escalation (75-78 Gy) was improved with PTV-based IMRT. However, dose-escalation with PTV-based IMRT was associated with increased OAR-doses, especially in high-dose areas. Conclusions: Probabilistic dose-escalated IMRT was feasible in this prospective study. Comparison of the CovP-concept with PTV-based IMRT revealed superiority with regard to target-coverage and sparing of OARs. The CovP-concept implements a robust plan optimization strategy for organ deformation and motions and could, therefore, serve as a less demanding compromise on the way to adaptive IGRT avoiding daily time-consuming re-planning. SUMMARY We evaluated the robustness of coverage probability (CovP)-based IMRT plans within a prospective study for prostate cancer radiotherapy. The treatment plans were compared with newly calculated conventional PTV-based IMRT plans. We were able to show that CovP led to a clearly more robust target coverage by avoiding hot spots at OARs compared to conventional PTV-based IMRT. In addition, negative consequences of an inflated PTV can be ameliorated by a more relaxed CovP-based dose prescription. Purpose: Cure- and toxicity rates of prostate IGRT can both be affected by ill-chosen planning target volume (PTV) margins. For dose-escalated prostate radiotherapy, we studied the potential for organ at risk (OAR) sparing and compensation of prostate motion with robust plan optimization using the coverage probability (CovP) concept compared to conventional PTV-based IMRT.Material and methods: We evaluated plan quality of CovP-plans for 27 intermediate risk prostate cancer patients treated in a prospective study (78 Gy/39 fractions). Clinical target volume (CTV) and OARs were contoured on three separate CTs to capture movement and deformation. To define the internal target volume (ITV), the union of CTV1-3 was encompassed by an isotropic margin of 7 mm for the planning process. CovP-dose distribution is optimized considering weight factors for IMRT constraints derived from probabilities of systematic organ displacement in the three CTs. CovP-dose volume histograms (DVHs) were compared with additionally calculated conventional PTV-based IMRT plans. PTV-based IMRT was planned on one-single CT with an isotropically expanded CTV to generate the PTV (i.e., CTV1 + 7mm) and was evaluated on the two other CTs.Results: The CovP-concept showed higher robustness in target volume coverage. Target miss was frequently observed with PTV-based IMRT, resulting in cold spots until 70 Gy with the CovP-concept. The target dose at 74 Gy was comparable, while further the dose-escalation (75-78 Gy) was improved with PTV-based IMRT. However, dose-escalation with PTV-based IMRT was associated with increased OAR-doses, especially in high-dose areas.Conclusions: Probabilistic dose-escalated IMRT was feasible in this prospective study. Comparison of the CovP-concept with PTV-based IMRT revealed superiority with regard to target-coverage and sparing of OARs. The CovP-concept implements a robust plan optimization strategy for organ deformation and motions and could, therefore, serve as a less demanding compromise on the way to adaptive IGRT avoiding daily time-consuming re-planning. SUMMARYWe evaluated the robustness of coverage probability (CovP)-based IMRT plans within a prospective study for prostate cancer radiotherapy. The treatment plans were compared with newly calculated conventional PTV-based IMRT plans. We were able to show that CovP led to a clearly more robust target coverage by avoiding hot spots at OARs compared to conventional PTV-based IMRT. In addition, negative consequences of an inflated PTV can be ameliorated by a more relaxed CovP-based dose prescription.Purpose: Cure- and toxicity rates of prostate IGRT can both be affected by ill-chosen planning target volume (PTV) margins. For dose-escalated prostate radiotherapy, we studied the potential for organ at risk (OAR) sparing and compensation of prostate motion with robust plan optimization using the coverage probability (CovP) concept compared to conventional PTV-based IMRT.Material and methods: We evaluated plan quality of CovP-plans for 27 intermediate risk prostate cancer patients treated in a prospective study (78 Gy/39 fractions). Clinical target volume (CTV) and OARs were contoured on three separate CTs to capture movement and deformation. To define the internal target volume (ITV), the union of CTV1-3 was encompassed by an isotropic margin of 7 mm for the planning process. CovP-dose distribution is optimized considering weight factors for IMRT constraints derived from probabilities of systematic organ displacement in the three CTs. CovP-dose volume histograms (DVHs) were compared with additionally calculated conventional PTV-based IMRT plans. PTV-based IMRT was planned on one-single CT with an isotropically expanded CTV to generate the PTV (i.e., CTV1 + 7mm) and was evaluated on the two other CTs.Results: The CovP-concept showed higher robustness in target volume coverage. Target miss was frequently observed with PTV-based IMRT, resulting in cold spots until 70 Gy with the CovP-concept. The target dose at 74 Gy was comparable, while further the dose-escalation (75-78 Gy) was improved with PTV-based IMRT. However, dose-escalation with PTV-based IMRT was associated with increased OAR-doses, especially in high-dose areas.Conclusions: Probabilistic dose-escalated IMRT was feasible in this prospective study. Comparison of the CovP-concept with PTV-based IMRT revealed superiority with regard to target-coverage and sparing of OARs. The CovP-concept implements a robust plan optimization strategy for organ deformation and motions and could, therefore, serve as a less demanding compromise on the way to adaptive IGRT avoiding daily time-consuming re-planning. SUMMARYWe evaluated the robustness of coverage probability (CovP)-based IMRT plans within a prospective study for prostate cancer radiotherapy. The treatment plans were compared with newly calculated conventional PTV-based IMRT plans. We were able to show that CovP led to a clearly more robust target coverage by avoiding hot spots at OARs compared to conventional PTV-based IMRT. In addition, negative consequences of an inflated PTV can be ameliorated by a more relaxed CovP-based dose prescription. |
Author | Alber, Markus Thorwarth, Daniela Bleif, Martin Wegener, Daniel Paulsen, Frank Müller, Arndt-Christian Zips, Daniel Dohm, Oliver Outaggarts, Zoulikha Berger, Bernhard |
Author_xml | – sequence: 1 givenname: Zoulikha surname: Outaggarts fullname: Outaggarts, Zoulikha organization: Department of Radiation Oncology, University Hospital Tübingen – sequence: 2 givenname: Daniel surname: Wegener fullname: Wegener, Daniel email: daniel.wegener@med.uni-tuebingen.de organization: Department of Radiation Oncology, University Hospital Tübingen – sequence: 3 givenname: Bernhard surname: Berger fullname: Berger, Bernhard organization: Clinic for Radiation Oncology, Oberschwaben Hospital Group – sequence: 4 givenname: Daniel surname: Zips fullname: Zips, Daniel organization: Department of Radiation Oncology, University Hospital Tübingen – sequence: 5 givenname: Frank surname: Paulsen fullname: Paulsen, Frank organization: Department of Radiation Oncology, University Hospital Tübingen – sequence: 6 givenname: Martin surname: Bleif fullname: Bleif, Martin organization: Clinic for Radiology and Radiation Oncology, ALB FILS Clinics Hospital on the Eichert – sequence: 7 givenname: Daniela surname: Thorwarth fullname: Thorwarth, Daniela organization: Department of Radiation Oncology, Section Medical Physics, University Hospital Tübingen – sequence: 8 givenname: Markus surname: Alber fullname: Alber, Markus organization: Clinic for Radiation Oncology, University Hospital Heidelberg – sequence: 9 givenname: Oliver surname: Dohm fullname: Dohm, Oliver organization: Department of Radiation Oncology, Section Medical Physics, University Hospital Tübingen – sequence: 10 givenname: Arndt-Christian orcidid: 0000-0002-6539-0682 surname: Müller fullname: Müller, Arndt-Christian organization: Department of Radiation Oncology, University Hospital Tübingen |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32436467$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1u1DAUha2qqJ0WHqGVl2zS-i-JIzagCtpKRSA0oO6sG8ceGSVxsJ2i4enrdKZdsICV5aPvXPuec4IORz8ahM4ouaBEkkvCpKCyur9ghGWprggXzQFa0aqkBWPV_SFaLUyxQMfoJMafhBDG6_IIHXMmeCWqeoXSGsLGJDy4GPEc3bjBX9c_ihai6fDt529rrP0wQci35HHw7RwT9lNyg_sDyfkRPzjIzIMJsDF4ygS0rndpm8VRmylhNy5yTJAM1pC18Bq9stBH82Z_nqLvnz6ur26Kuy_Xt1cf7gotKE-FqVmtiWgsa23-utQlFdySupOslqYztG0awmvJZEObshNgoRSWVowaymVe8RS93c3N7_-aTUwqr6lN38No_BwVE6TkPIfRZPR8j87tYDo1BTdA2KrnpDJQ7gCdd4nB2BeEErU0op4bUUsjat9I9r37y6ddekouBXD9f93vd243Wh8G-O1D36kE294HG3KYLir-7xGP1TikXQ |
CitedBy_id | crossref_primary_10_3390_cancers16050892 crossref_primary_10_1002_mp_17023 crossref_primary_10_2478_raon_2020_0075 crossref_primary_10_1016_j_phro_2022_02_013 |
Cites_doi | 10.1371/journal.pone.0154499 10.1016/S0167-8140(18)31915-7 10.1016/j.radonc.2017.01.015 10.1016/j.clon.2012.05.002 10.1016/j.radonc.2016.04.014 10.1016/j.radonc.2017.10.029 10.1186/1471-2407-13-27 10.1016/j.zemedi.2016.02.002 10.1016/j.ijrobp.2006.07.013 10.1088/0031-9155/60/2/549 10.1016/j.radonc.2014.02.009 10.1016/j.ijrobp.2009.07.1754 10.1088/1361-6560/aae659 10.1016/S0360-3016(00)00700-8 10.1016/j.radonc.2005.06.006 10.1016/j.ijrobp.2008.10.091 10.1016/j.ijrobp.2009.01.062 10.1016/S1470-2045(16)30102-4 10.1016/j.radonc.2005.09.005 10.1016/S0360-3016(00)00608-8 |
ContentType | Journal Article |
Copyright | 2020 Acta Oncologica Foundation 2020 |
Copyright_xml | – notice: 2020 Acta Oncologica Foundation 2020 |
DBID | AAYXX CITATION NPM 7X8 |
DOI | 10.1080/0284186X.2020.1760349 |
DatabaseName | CrossRef PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1651-226X |
EndPage | 917 |
ExternalDocumentID | 32436467 10_1080_0284186X_2020_1760349 1760349 |
Genre | Article Journal Article |
GroupedDBID | --- 00X 03L 0BK 23M 2WC 36B 4.4 5GY 5RE 6J9 AALUX AAMIU AAPUL AAWTL ABDBF ABEIZ ABJNI ABLIJ ABLJU ABLKL ABNNA ABUPF ABXYU ACENM ACGEJ ACGFO ACGFS ACIEZ ACUHS ADBBV ADCVX ADRBQ ADXPE AECIN AEGXH AENEX AEOZL AEXWM AFKVX AGDLA AGFJD AGYJP AIAGR AIJEM AJWEG AKBVH ALMA_UNASSIGNED_HOLDINGS ALQZU ALYBC BABNJ BAWUL BLEHA BOHLJ CCCUG COF CS3 DIK DKSSO EAP EBB EBC EBD EBS EBX EMB EMK EMOBN EPL ESX F5P GROUPED_DOAJ GX1 H13 HZ~ KRBQP KSSTO KWAYT KYCEM L7B LJTGL M4Z O9- OK1 P2P SV3 TBQAZ TDBHL TERGH TFDNU TFL TFW TUS UEQFS V1S WH7 ~1N AAFWJ AAYXX AFPKN CITATION PGMZT NPM 7X8 |
ID | FETCH-LOGICAL-c413t-e727c049f2bf0028c5143f07d8278ede1b990378289195d4afa54f1621e138243 |
ISSN | 0284-186X 1651-226X |
IngestDate | Fri Jul 11 07:43:05 EDT 2025 Mon Jul 21 06:06:41 EDT 2025 Thu Apr 24 22:52:04 EDT 2025 Wed Sep 03 16:40:42 EDT 2025 Wed Dec 25 09:08:29 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c413t-e727c049f2bf0028c5143f07d8278ede1b990378289195d4afa54f1621e138243 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0002-6539-0682 |
OpenAccessLink | https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2020.1760349?needAccess=true |
PMID | 32436467 |
PQID | 2405333249 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | pubmed_primary_32436467 crossref_primary_10_1080_0284186X_2020_1760349 proquest_miscellaneous_2405333249 crossref_citationtrail_10_1080_0284186X_2020_1760349 informaworld_taylorfrancis_310_1080_0284186X_2020_1760349 |
PublicationCentury | 2000 |
PublicationDate | 2020-08-02 |
PublicationDateYYYYMMDD | 2020-08-02 |
PublicationDate_xml | – month: 08 year: 2020 text: 2020-08-02 day: 02 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Acta oncologica |
PublicationTitleAlternate | Acta Oncol |
PublicationYear | 2020 |
Publisher | Taylor & Francis |
Publisher_xml | – name: Taylor & Francis |
References | Wegener D (CIT0021) CIT0010 CIT0020 CIT0001 CIT0012 CIT0023 CIT0011 CIT0022 Leitlinienprogramm Onkologie der AWMW DKeVu, e.V DK. (CIT0004) 2018 CIT0003 CIT0014 CIT0002 CIT0013 CIT0005 CIT0016 CIT0015 CIT0007 CIT0018 CIT0006 CIT0017 CIT0009 CIT0008 CIT0019 |
References_xml | – ident: CIT0001 doi: 10.1371/journal.pone.0154499 – ident: CIT0013 doi: 10.1016/S0167-8140(18)31915-7 – ident: CIT0019 doi: 10.1016/j.radonc.2017.01.015 – ident: CIT0002 doi: 10.1016/j.clon.2012.05.002 – ident: CIT0022 doi: 10.1016/j.radonc.2016.04.014 – ident: CIT0017 doi: 10.1016/j.radonc.2017.10.029 – ident: CIT0009 doi: 10.1186/1471-2407-13-27 – ident: CIT0005 doi: 10.1016/j.zemedi.2016.02.002 – start-page: 88 ident: CIT0021 publication-title: Acta Oncol – ident: CIT0023 doi: 10.1016/j.ijrobp.2006.07.013 – ident: CIT0003 – ident: CIT0018 doi: 10.1088/0031-9155/60/2/549 – start-page: 1 year: 2018 ident: CIT0004 publication-title: German S3-Guideline – ident: CIT0006 doi: 10.1016/j.radonc.2014.02.009 – ident: CIT0016 doi: 10.1016/j.ijrobp.2009.07.1754 – ident: CIT0014 doi: 10.1088/1361-6560/aae659 – ident: CIT0007 doi: 10.1016/S0360-3016(00)00700-8 – ident: CIT0012 doi: 10.1016/j.radonc.2005.06.006 – ident: CIT0015 doi: 10.1016/j.ijrobp.2008.10.091 – ident: CIT0008 doi: 10.1016/j.ijrobp.2009.01.062 – ident: CIT0010 doi: 10.1016/S1470-2045(16)30102-4 – ident: CIT0011 doi: 10.1016/j.radonc.2005.09.005 – ident: CIT0020 doi: 10.1016/S0360-3016(00)00608-8 |
SSID | ssj0002375 |
Score | 2.3032694 |
Snippet | Purpose: Cure- and toxicity rates of prostate IGRT can both be affected by ill-chosen planning target volume (PTV) margins. For dose-escalated prostate... Cure- and toxicity rates of prostate IGRT can both be affected by ill-chosen planning target volume (PTV) margins. For dose-escalated prostate radiotherapy, we... |
SourceID | proquest pubmed crossref informaworld |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 911 |
Title | Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer |
URI | https://www.tandfonline.com/doi/abs/10.1080/0284186X.2020.1760349 https://www.ncbi.nlm.nih.gov/pubmed/32436467 https://www.proquest.com/docview/2405333249 |
Volume | 59 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9NAFB5BKlW9IHbKpkHiZjnq2OMlxxaoClIQQimKuFj2LGkFtatkggS_nvdmcVyUqsDFiuwZ28n3Zfy957cQ8jpNC5aBEI9BLuuYs1rHjRQ6znnGZJNomWn0d0w_5ien_MM8m28CMm12iWnG4tfWvJL_QRX2Aa6YJfsPyPYnhR3wGfCFLSAM27_D2IZxRwDVKlpbo__T7EuMDyYZvZ9-nm0izEFhLrtmvTJRB2vEhU--jH6c1zAGvjdG7mBvGVe1-ycGo2O8i40xx7wQUKQYHyZ8LG8oWytMHcFIv4D2Dtu1qRcLuF_Lka_Yc_3b2Wb5Vwvls2xcfnvvEcBEUOc8UMs2pPtbr7Z_XTEY7x0ViQuTcyutcotrnrEY5N58sGCyrcu4j3uERycr8_kYzzZmRY61dIbjAY3LC4styMI0566xxx_1s8Oh22QnKUBfjcjO4dHbo-P-eZ2kRRZyu7Dq-rar7pHdcJ4rAuZKedvrjRQrVmZ3yR1vZdBDR5l75JZq75PdqY-jeECMYw5F5lDLHNozhyJzaGAONR11zKFD5lBgDg3MoQPmUM8cet7SwBzqmPOQnB6_m705iX3_jViAtDGxAm0rwILUSaPRNhcorvVBIcukKJVUrAEpkxZos7NJJnmt64xrlidMYWVLnj4io7Zr1RNCJ7IuuTwQuhGKK5jBy0yIEtvR5YnMm33Cw49aCV-cHnukfK9YqGHrYakQlsrDsk_G_bRLV53lpgmTIWKVsW4x7XrYVOkNc18FeCuAB1-s1a3q1qsKVDFYTUAQGPPY4d7fTqDN02uPPCN7m7_LczIyy7V6AUrXNC89VX8DaTak2w |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Target+miss+using+PTV-based+IMRT+compared+to+robust+optimization+via+coverage+probability+concept+in+prostate+cancer&rft.jtitle=Acta+oncologica&rft.au=Outaggarts%2C+Zoulikha&rft.au=Wegener%2C+Daniel&rft.au=Berger%2C+Bernhard&rft.au=Zips%2C+Daniel&rft.date=2020-08-02&rft.eissn=1651-226X&rft.spage=1&rft_id=info:doi/10.1080%2F0284186X.2020.1760349&rft_id=info%3Apmid%2F32436467&rft.externalDocID=32436467 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0284-186X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0284-186X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0284-186X&client=summon |